INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the recipient of a large growth in short interest in June. As of June 15th, there was short interest totalling 75,600 shares, a growth of 144.7% from the May 31st total of 30,900 shares. Based on an average daily trading volume, of 3,800,000 shares, the short-interest ratio is currently 0.0 days. Currently, 2.0% of the shares of the stock are sold short.
Institutional Trading of INVO Bioscience
An institutional investor recently bought a new position in INVO Bioscience stock. Sabby Management LLC acquired a new position in shares of INVO Bioscience, Inc. (NASDAQ:INVO – Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 231,023 shares of the company’s stock, valued at approximately $183,000. INVO Bioscience makes up 0.1% of Sabby Management LLC’s holdings, making the stock its 29th biggest holding. Sabby Management LLC owned about 9.43% of INVO Bioscience at the end of the most recent reporting period. 12.02% of the stock is currently owned by institutional investors.
INVO Bioscience Trading Down 3.3 %
INVO traded down $0.03 during midday trading on Friday, hitting $0.84. 19,222 shares of the company traded hands, compared to its average volume of 124,025. The business has a 50 day simple moving average of $0.94 and a two-hundred day simple moving average of $1.03. The company has a debt-to-equity ratio of 2.94, a quick ratio of 0.16 and a current ratio of 0.19. INVO Bioscience has a 52-week low of $0.50 and a 52-week high of $7.20.
About INVO Bioscience
INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Read More
- Five stocks we like better than INVO Bioscience
- Election Stocks: How Elections Affect the Stock Market
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Why Invest in 5G? How to Invest in 5G Stocks
- MarketBeat Week in Review – 6/24 – 6/28
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.